Business Description
Kymera Therapeutics is a clinical-stage drug development company founded in 2015 and based in Watertown, Massachusetts. The company creates oral medicines that work by directing the body's own waste-disposal system to eliminate proteins that drive disease. Its pipeline targets conditions ranging from skin and lung diseases to autoimmune disorders and cancer, with several candidates already in human trials. Kymera also partners with Sanofi to advance one of its key programs in immunology and inflammation.
